SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-22-018767
Filing Date
2022-05-12
Accepted
2022-05-12 08:30:29
Documents
5
Period of Report
2022-05-12

Document Format Files

Seq Description Document Type Size
1 6-K brhc10037458_6k.htm 6-K 11780
2 EXHIBIT 99.1 brhc10037458_ex99-1.htm EX-99.1 480419
3 EXHIBIT 99.2 brhc10037458_ex99-2.htm EX-99.2 172956
4 EXHIBIT 99.3 brhc10037458_ex99-3.htm EX-99.3 262086
5 image00007.jpg GRAPHIC 36872
  Complete submission text file 0001140361-22-018767.txt   979146
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 22915835
SIC: 2834 Pharmaceutical Preparations